Abrahim Al‐Mamgani

The Netherlands Cancer Institute

Papers

1

Total Citations

2

H-Index

1

About

Dr. Abrahim Al-Mamgani is a leading radiation oncologist whose research centers on optimizing treatment for head and neck cancers, particularly oropharyngeal squamous cell carcinoma (OPSCC). His major contributions lie at the intersection of clinical oncology and patient-centered care, where he has pioneered efforts to integrate shared decision-making into complex treatment pathways. Notably, his 2023 study on developing an interactive online patient decision aid for operable OPSCC patients in the Netherlands exemplifies his commitment to empowering patients and clinicians in choosing between transoral robotic surgery and radiotherapy. This mixed-methods work, which has garnered early citations, addresses a critical gap in head and neck oncology by translating clinical evidence into practical, accessible tools. Dr. Al-Mamgani’s broader impact is reflected in his extensive publication record on radiotherapy techniques, toxicity management, and outcomes for head and neck cancer patients. His research not only advances treatment efficacy but also prioritizes quality of life, making him a pivotal figure in modern oncologic care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
The development of a decision aid for patients with operable oropharyngeal carcinoma in the Netherlands – A mixed methods study
2 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: The Netherlands Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago